drugset / Trial / NCT03378466
Heparin Anticoagulation in Septic Shock
Phase 2
Terminated
178 enrolled
University of Manitoba
Canadian Institutes of Health Research (CIHR) · collabCancerCare Manitoba · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is a pragmatic open-label international randomized trial comparing therapeutic dose intravenous unfractionated heparin (UFH) to standard care venous thromboprophylaxis in patients diagnosed with septic shock.
Timeline
- Start
- 2018-03-12
- Primary completion
- 2021-12-31
- Completion
- 2021-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Heparin | Other / unclassified | 18 iu/kg | Intravenous |